Últimas publicaciones
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?
United European Gastroenterol J. 2022 Mar;10(2):141-142.
D'Amico F, Zilli A, Fiorino G.
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future
J Clin Med. 2022 Jan 24;11(3):569.
Solitano V, Zilli A, Franchellucci G, Allocca M, Fiorino G, Furfaro F, D'Amico F, Danese S, Al Awadhi S.
JAK inhibitors in crohn's disease: ready to go?
Expert Opin Investig Drugs. 2022 Feb;31(2):145-161.
Dell'Avalle C, D'Amico F, Gabbiadini R, Dal Buono A, Pugliese N, Zilli A, Furfaro F, Fiorino G, Allocca M, Peyrin-Biroulet L, Danese S.
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases
J Clin Med. 2022 Feb 7;11(3):872.
Parigi TL, Mastrorocco E, Da Rio L, Allocca M, D'Amico F, Zilli A, Fiorino G, Danese S, Furfaro F.
Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows
J Clin Med. 2022 Jan 12;11(2):353.
Alfarone L, Dal Buono A, Craviotto V, Zilli A, Fiorino G, Furfaro F, D'Amico F, Danese S, Allocca M.
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
J Clin Med. 2022 Jan 20;11(3):509.
Gabbiadini R, D'Amico F, De Marco A, Terrin M, Zilli A, Furfaro F, Allocca M, Fiorino G, Danese S.
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques
Chin Clin Oncol. 2022 Jun;11(3):22.
Furfaro F, Dal Buono A, Sicuso C, Allocca M, D'Amico F, Zilli A, Fiorino G, Gabbiadini R, Danese S.
Gastrointestinal system, COVID-19 and potential mechanisms associated with coagulopathy
Curr Drug Targets. 2022 Sep 22.
Furfaro F, Gabbiadini R, D'Amico F, Zilli A, Buono AD, Allocca M, Fiorino G, Danese S.
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Inflamm Bowel Dis. 2022 Aug 30:izac189.
Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study
Clin Gastroenterol Hepatol. 2022 Apr;20(4):e723-e740.
Allocca M, Craviotto V, Bonovas S, Furfaro F, Zilli A, Peyrin-Biroulet L, Fiorino G, Danese S.
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study
United European Gastroenterol J. 2022 Mar;10(2):190-197.
Allocca M, Dell'Avalle C, Craviotto V, Furfaro F, Zilli A, D'Amico F, Bonovas S, Peyrin-Biroulet L, Fiorino G, Danese S.
Ulcerative colitis: Impact of early disease clearance on long-term outcomes
D'Amico F, Fiorino G, Solitano V, Massarini E, Guillo L, Allocca M, Furfaro F, Zilli A, Bonovas S, Magro F, Peyrin-Biroulet L, Danese S.
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease
Aliment Pharmacol Ther. 2022 Feb;55(4):446-454.
A multicenter cohort study. United European Gastroenterol J. 2022 Sep;10(7):775-782. - Allocca M, Craviotto V, Dell'Avalle C, Furfaro F, Zilli A, D'Amico F, Bonovas S, Peyrin-Biroulet L, Fiorino G, Danese S.
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience
Inflamm Bowel Dis. 2022 May 28:izac110.
D'Amico F, Tasopoulou O, Fiorino G, Zilli A, Furfaro F, Allocca M, Sileri P, Spinelli A, Peyrin-Biroulet L, Danese S.
A New Potential Target in the Treatment of Inflammatory Bowel Disease
Curr Drug Targets. 2021;22(7):760-769.
Furfaro F, Alfarone L, Gilardi D, Correale C, Allocca M, Fiorino G, Argollo M, Zilli A, Zacharopoulou E, Loy L, Roda G, Danese S. TL1A:
